HSPA1A and cancer: With the development of cancer therapies targeting HSP70s, there are still quite a few promising anti-cancer inhibitors that directly or indirectly target HSP70 and have not clearly demonstrated the exact binding site on HSP70 or the effect on HSP70 activity.